LLY · News · 20260827N
Products and Technology - Alzheimer’s Blood Test
ELI LILLY & Co · 2026-08-27 · Importance 7 · Surprise 60 · In source text
The FDA cleared an Alzheimer’s blood test developed by Eli Lilly and Roche on August 27, 2026. The clearance supports use of a blood-based diagnostic in Alzheimer’s disease assessment and highlights expansion of the diagnostics market. The report did not disclose revenue, pricing, reimbursement, or implementation timelines for the test.
Key facts
- The U.S. Food and Drug Administration granted clearance for Lilly and Roche's Alzheimer's blood test. source
- The Alzheimer's blood test is a Lilly-Roche collaboration (referred to as Lilly-Roche's Alzheimer's Blood Test). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | The U.S. Food and Drug Administration granted clearance for Lilly and Roche's Alzheimer's blood test. |